McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.47% ...

Shares of Cencora Inc. COR inched 0.47% higher to $249.97 Wednesday, on what proved to be an all-around favorable trading ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...

A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Revenue: US$294.0b (up 12% from FY 2023). Net income: US$1.51b (down 14% from FY 2023). Profit margin: 0.5% (down from 0.7% ...

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 6.7% over the past month. The stock hit a new 52-week high of $251.56 in the previous session.

Analyst Charles Rhyee of TD Cowen maintained a Buy rating on Cencora (COR – Research Report), with a price target of $288.00. Charles ...

Shares of Cencora Inc. COR shed 2.62% to $243.41 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.60% to 5,949.17 and ...